Publications by authors named "Irving Gomolin"

Claim this Profile
R
Role of Apolipoprotein E in Alzheimer's Disease Pathogenesis, Prognosis and Treatment.
Allison B Reiss, Mary Housny, Shelly Gulkarov, Tahmina Hossain, Brandon Locke, Irving H Gomolin

Discov Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib as a Prospective Treatment for Alzheimer's Disease: Effect on Proteins Involved in Neurodegeneration and Neuronal Homeostasis.
Ankita Srivastava, Heather A Renna, Maryann Johnson, Katie Sheehan, Saba Ahmed, Irving H Gomolin

Life (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondria in Alzheimer's Disease Pathogenesis.
Allison B Reiss, Shelly Gulkarov, Benna Jacob, Ankita Srivastava, Aaron Pinkhasov, Irving H Gomolin

Life (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of P110 Peptide: New Insights into Treatment of Alzheimer's Disease.
Ankita Srivastava, Maryann Johnson, Heather A Renna, Katie M Sheehan, Saba Ahmed, Irving H Gomolin

Life (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's Disease Treatment: The Search for a Breakthrough.
Allison B Reiss, Dalia Muhieddine, Berlin Jacob, Michael Mesbah, Aaron Pinkhasov, Irving H Gomolin

Medicina (Kaunas)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model.
Lora J Kasselman, Heather A Renna, Iryna Voloshyna, Aaron Pinkhasov, Irving H Gomolin

J Tradit Complement Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.
Allison B Reiss, Saba Ahmed, Christopher Dayaramani, Amy D Glass, Irving H Gomolin

Exp Gerontol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of COVID-19 Disease Among Chronically Ventilated Nursing Home Patients.
Irving H Gomolin, Grigoriy Krichmar, David Siskind, Jasmin Divers, Bruce Polsky

J Am Med Dir Assoc· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-acute care nursing home deaths in the COVID era: Potential for attribution bias.
Irving H Gomolin, Douglas A Hartley, Bruce Polsky

J Am Geriatr Soc· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer Disease Clinical Trials Targeting Amyloid: Lessons Learned From Success in Mice and Failure in Humans.
Allison B Reiss, Natalie Montufar, Joshua DeLeon, Aaron Pinkhasov, Irving H Gomolin

Neurologist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of oxytocin on lipid accumulation under inflammatory conditions in human macrophages.
Ariel Karten, Nicholas A Vernice, Heather A Renna, Steven E Carsons, Joshua DeLeon, Irving H Gomolin

Exp Mol Pathol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease: many failed trials, so where do we go from here?
Allison Bethanne Reiss, Amy D Glass, Thomas Wisniewski, Benjamin Wolozin, Irving H Gomolin

J Investig Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Asymptomatic Bacteriuria is not Asymptomatic or "Pseudo-Urinary Tract Infection".
Irving H Gomolin

J Am Geriatr Soc· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages.
Iryna Voloshyna, Lora J Kasselman, Steven E Carsons, Michael J Littlefield, Irving H Gomolin

J Investig Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine Plasma Concentrations Among Patients With Dementia.
Irving H Gomolin, Michael J Papamichael, Melissa J Fazzari, Robert Rieger

J Clin Psychopharmacol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.
Thomas M Jeitner, Mike Kalogiannis, Boris F Krasnikov, Irving Gomolin, Morgan R Peltier

Toxicol Sci· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.
Thomas M Jeitner, Mike Kalogiannis, Boris F Krasnikov, Irving Gomolin, Morgan R Peltier

Toxicol Sci· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of computerized physician order entry alerts on prescribing in older patients.
Paula E Lester, Liliana Rios-Rojas, Shahidul Islam, Melissa J Fazzari, Irving H Gomolin

Drugs Aging· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine standard tablet and extended-release dosing considerations: a pharmacokinetic analysis.
Sum Lam, Candace Smith, Irving H Gomolin

J Am Geriatr Soc· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donepezil dosing strategies: pharmacokinetic considerations.
Irving H Gomolin, Candace Smith, Thomas M Jeitner

J Am Med Dir Assoc· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholinesterase inhibitors: applying pharmacokinetics to clinical decision making.
Irving H Gomolin, Candace Smith, Thomas M Jeitner

Am J Geriatr Pharmacother· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily memantine: pharmacokinetic and clinical considerations.
Irving H Gomolin, Candace Smith, Thomas M Jeitner

J Am Geriatr Soc· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internal medicine residents' perception of nursing home demographics and regulations: a pilot study.
Paula E Lester, Maria Doubrovskaia, Maha Ghosn, Irving H Gomolin

J Am Med Dir Assoc· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older is colder: observations on body temperature among nursing home subjects.
Irving H Gomolin, Paula Lester, Simcha Pollack

J Am Med Dir Assoc· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.
Sum Lam, Irving H Gomolin

Pharmacotherapy· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis